{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:56:36Z","timestamp":1781996196978,"version":"3.54.5"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Mashhad University of Medical Sciences Vice-Chancellor for Research","award":["941406"],"award-info":[{"award-number":["941406"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04566-x","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T10:59:12Z","timestamp":1731149952000},"page":"5156-5182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-0947","authenticated-orcid":false,"given":"Parisa","family":"Shoae-Hagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7450-9286","authenticated-orcid":false,"given":"Bibi Marjan","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-6897","authenticated-orcid":false,"given":"Hamid Reza","family":"Sadeghnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-2343","authenticated-orcid":false,"given":"Soghra","family":"Mehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-5448","authenticated-orcid":false,"given":"Gholamreza","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-851X","authenticated-orcid":false,"given":"Hossein","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"4566_CR1","unstructured":"Vasan S, Padhy RK (2023) Tardive dyskinesia. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448207"},{"issue":"4","key":"4566_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.9758\/cpn.2020.18.4.493","volume":"18","author":"SN Caroff","year":"2020","unstructured":"Caroff SN (2020) Recent advances in the pharmacology of tardive dyskinesia. Clin Psychopharmacol Neurosci 18(4):493","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"4566_CR3","doi-asserted-by":"publisher","unstructured":"Waln O, Jankovic J (2013) An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y) 3. https:\/\/doi.org\/10.7916\/D88P5Z71","DOI":"10.7916\/D88P5Z71"},{"issue":"4","key":"4566_CR4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","volume":"157","author":"S Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157(4):514\u2013520","journal-title":"Am J Psychiatry"},{"issue":"2","key":"4566_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s002130000532","volume":"152","author":"S Silvestri","year":"2000","unstructured":"Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, Kapur S, Zipursky RB, et al (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152(2):174\u2013180. https:\/\/doi.org\/10.1007\/s002130000532","journal-title":"Psychopharmacology"},{"issue":"7","key":"4566_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1176\/ajp.153.7.948","volume":"153","author":"S Kapur","year":"1996","unstructured":"Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R (1996) High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 153(7):948\u2013950","journal-title":"Am J Psychiatry"},{"issue":"2","key":"4566_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00213-002-1259-z","volume":"165","author":"P Turrone","year":"2003","unstructured":"Turrone P, Remington G, Kapur S, Nobrega JN (2003) The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats. Psychopharmacology 165(2):166\u2013171. https:\/\/doi.org\/10.1007\/s00213-002-1259-z","journal-title":"Psychopharmacology"},{"key":"4566_CR8","doi-asserted-by":"publisher","unstructured":"Turrone P, Remington G, Kapur S, Nobrega JN (2003) Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats. Neuropsychopharmacol 28 (8):1433\u20131439. https:\/\/doi.org\/10.1038\/sj.npp.1300233","DOI":"10.1038\/sj.npp.1300233"},{"issue":"3","key":"4566_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","volume":"26","author":"P Turrone","year":"2002","unstructured":"Turrone P, Remington G, Nobrega JN (2002) The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy? Neurosci Biobehav Rev 26(3):361\u2013380","journal-title":"Neurosci Biobehav Rev"},{"key":"4566_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2018.06.012","volume":"192","author":"S Aringhieri","year":"2018","unstructured":"Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU et al (2018) Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences. Pharmacol Ther 192:20\u201341","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4566_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P Seeman","year":"2002","unstructured":"Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47(1):27\u201338","journal-title":"Can J Psychiatry"},{"issue":"4","key":"4566_CR12","first-page":"5","volume":"61","author":"GW Arana","year":"2000","unstructured":"Arana GW (2000) An overview of side effects caused by typical antipsychotics. J Clin Psychiatry 61(4):5\u201313","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"4566_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","volume":"155","author":"G Tsai","year":"1998","unstructured":"Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT (1998) Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 155(9):1207\u20131213. https:\/\/doi.org\/10.1176\/ajp.155.9.1207","journal-title":"Am J Psychiatry"},{"issue":"1","key":"4566_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","volume":"17","author":"JB Lohr","year":"2003","unstructured":"Lohr JB, Kuczenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17(1):47\u201362. https:\/\/doi.org\/10.2165\/00023210-200317010-00004","journal-title":"CNS Drugs"},{"key":"4566_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pnpbp.2012.10.018","volume":"46","author":"CH Cho","year":"2013","unstructured":"Cho CH, Lee HJ (2013) Oxidative stress and tardive dyskinesia: pharmacogenetic evidence. Prog Neuropsychopharmacol Biol Psychiatry 46:207\u2013213. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"4566_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020070089","volume":"107","author":"R Galili-Mosberg","year":"2000","unstructured":"Galili-Mosberg R, Gil-Ad I, Weizman A, Melamed E, Offen D (2000) Haloperidol\u2013induced neurotoxicity\u2013possible implications for tardive dyskinesia. J Neural Transm 107(4):479\u2013490","journal-title":"J Neural Transm"},{"issue":"1\u20133","key":"4566_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2008.06.033","volume":"590","author":"M Bishnoi","year":"2008","unstructured":"Bishnoi M, Chopra K, Kulkarni SK (2008) Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia. Eur J Pharmacol 590(1\u20133):241\u2013245","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"4566_CR18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.pnpbp.2008.05.003","volume":"32","author":"M Bishnoi","year":"2008","unstructured":"Bishnoi M, Chopra K, Kulkarni SK (2008) Differential striatal levels of TNF-\u03b1, NF\u03baB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 32(6):1473\u20131478","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4566_CR19","first-page":"2499","volume":"19","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Zhang X, Lu X, Li Y, Lu C, Chi J, Ma Y, Shi X et al (2023) Genetic susceptibility to tardive dyskinesia and cognitive impairments in Chinese Han schizophrenia: role of oxidative stress-related and adenosine receptor genes. Neuropsychiatr DisTreat 19:2499\u20132509","journal-title":"Neuropsychiatr DisTreat"},{"key":"4566_CR20","doi-asserted-by":"crossref","first-page":"834129","DOI":"10.3389\/fphar.2021.834129","volume":"12","author":"EE Tsermpini","year":"2022","unstructured":"Tsermpini EE, Reden\u0161ek S, Dol\u017ean V (2022) Genetic factors associated with tardive dyskinesia: from pre-clinical models to clinical studies. Front Pharmacol 12:834129","journal-title":"Front Pharmacol"},{"issue":"5","key":"4566_CR21","first-page":"535","volume":"153","author":"D Casey","year":"1990","unstructured":"Casey D (1990) Tardive dyskinesia. Western J Med 153(5):535","journal-title":"Western J Med"},{"key":"4566_CR22","doi-asserted-by":"crossref","first-page":"100687","DOI":"10.1016\/j.bbih.2023.100687","volume":"33","author":"AJ Loonen","year":"2023","unstructured":"Loonen AJ (2023) Putative role of immune reactions in the mechanism of tardive dyskinesia. Brain, Behavior, Immunity-Health 33:100687","journal-title":"Brain, Behavior, Immunity-Health"},{"key":"4566_CR23","first-page":"1767989","volume":"1","author":"Q Wu","year":"2022","unstructured":"Wu Q, Yuan F, Zhang S, Liu W, Miao Q, Zheng X, Lu S, Hou K (2022) Correlation of blood biochemical markers with tardive dyskinesia in schizophrenic patients. Dis Markers 1:1767989","journal-title":"Dis Markers"},{"issue":"8","key":"4566_CR24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/1440-1681.13671","volume":"49","author":"J Osacka","year":"2022","unstructured":"Osacka J, Kiss A, Pirnik Z (2022) Possible involvement of apoptosis in the antipsychotics side effects: a mini-review. Clin Exp Pharmacol Physiol 49(8):836\u2013847","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4566_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2024.04.017","volume":"269","author":"N Li","year":"2024","unstructured":"Li N, Li Y, Yu T, Gou M, Chen W, Wang X, Tong J, Chen S et al (2024) Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia. Schizophr Res 269:36\u201347","journal-title":"Schizophr Res"},{"key":"4566_CR26","doi-asserted-by":"crossref","first-page":"204512532211173","DOI":"10.1177\/20451253221117313","volume":"12","author":"H Takeuchi","year":"2022","unstructured":"Takeuchi H, Mori Y, Tsutsumi Y (2022) Pathophysiology, prognosis and treatment of tardive dyskinesia. Therapeutic Adv Psychopharmacol 12:20451253221117310","journal-title":"Therapeutic Adv Psychopharmacol"},{"key":"4566_CR27","doi-asserted-by":"crossref","first-page":"109682","DOI":"10.1016\/j.mehy.2020.109682","volume":"140","author":"Z Ali","year":"2020","unstructured":"Ali Z, Roque A, El-Mallakh RS (2020) A unifying theory for the pathoetiologic mechanism of tardive dyskinesia. Med Hypotheses 140:109682","journal-title":"Med Hypotheses"},{"issue":"7603","key":"4566_CR28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature17639","volume":"533","author":"EA Yttri","year":"2016","unstructured":"Yttri EA, Dudman JT (2016) Opponent and bidirectional control of movement velocity in the basal ganglia. Nature 533(7603):402\u2013406","journal-title":"Nature"},{"issue":"1","key":"4566_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuron.2016.08.037","volume":"92","author":"G Barbera","year":"2016","unstructured":"Barbera G, Liang B, Zhang L, Gerfen CR, Culurciello E, Chen R, Li Y, Lin D-T (2016) Spatially compact neural clusters in the dorsal striatum encode locomotion relevant information. Neuron 92(1):202\u2013213","journal-title":"Neuron"},{"issue":"9","key":"4566_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/070674370505000907","volume":"50","author":"HC Margolese","year":"2005","unstructured":"Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R (2005) Tardive dyskinesia in the era of typical and atypical antipsychotics Part 1.: pathophysiology and mechanisms of induction. Can J Psychiatry 50(9):541\u2013547. https:\/\/doi.org\/10.1177\/070674370505000907","journal-title":"Can J Psychiatry"},{"issue":"Suppl 4","key":"4566_CR31","first-page":"5","volume":"61","author":"DE Casey","year":"2000","unstructured":"Casey DE (2000) Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry 61(Suppl 4):5\u20139","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4566_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.baga.2016.02.001","volume":"6","author":"D Sulzer","year":"2016","unstructured":"Sulzer D, Cragg SJ, Rice ME (2016) Striatal dopamine neurotransmission: regulation of release and uptake. Basal ganglia 6(3):123\u2013148","journal-title":"Basal ganglia"},{"issue":"1","key":"4566_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","volume":"76","author":"NX Tritsch","year":"2012","unstructured":"Tritsch NX, Sabatini BL (2012) Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76(1):33\u201350","journal-title":"Neuron"},{"issue":"7","key":"4566_CR34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","volume":"58","author":"DM Lovinger","year":"2010","unstructured":"Lovinger DM (2010) Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 58(7):951\u2013961","journal-title":"Neuropharmacology"},{"issue":"10","key":"4566_CR35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.25107","volume":"27","author":"JT Teo","year":"2012","unstructured":"Teo JT, Edwards MJ, Bhatia K (2012) Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis. Mov Disord 27(10):1205\u20131215","journal-title":"Mov Disord"},{"issue":"7989","key":"4566_CR36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41586-023-06727-9","volume":"623","author":"S Pidathala","year":"2023","unstructured":"Pidathala S, Liao S, Dai Y, Li X, Long C, Chang C-L, Zhang Z, Lee C-H (2023) Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2. Nature 623(7989):1086\u20131092","journal-title":"Nature"},{"issue":"6","key":"4566_CR37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FBP.0000000000000563","volume":"31","author":"AM Szota","year":"2020","unstructured":"Szota AM, Scheel-Kr\u00fcger J (2020) The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results. Behav Pharmacol 31(6):511\u2013523","journal-title":"Behav Pharmacol"},{"key":"4566_CR38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2018.11.004","volume":"122","author":"KG Mulvihill","year":"2019","unstructured":"Mulvihill KG (2019) Presynaptic regulation of dopamine release: role of the DAT and VMAT2 transporters. Neurochem Int 122:94\u2013105","journal-title":"Neurochem Int"},{"issue":"1","key":"4566_CR39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2010.05906.x","volume":"1216","author":"LE Eiden","year":"2011","unstructured":"Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216(1):86\u201398","journal-title":"Ann N Y Acad Sci"},{"key":"4566_CR40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","volume":"460","author":"A Lau","year":"2010","unstructured":"Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pfl\u00fcgers Archiv-Eur J Physiol 460:525\u2013542","journal-title":"Pfl\u00fcgers Archiv-Eur J Physiol"},{"issue":"7","key":"4566_CR41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0040-4020(82)85068-0","volume":"38","author":"C Walsh","year":"1982","unstructured":"Walsh C (1982) Suicide substrates: mechanism-based enzyme inactivators. Tetrahedron 38(7):871\u2013909","journal-title":"Tetrahedron"},{"issue":"1","key":"4566_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev.bi.53.070184.002425","volume":"53","author":"CT Walsh","year":"1984","unstructured":"Walsh CT (1984) Suicide substrates, mechanism-based enzyme inactivators: recent developments. Annu Rev Biochem 53(1):493\u2013535. https:\/\/doi.org\/10.1146\/annurev.bi.53.070184.002425","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"4566_CR43","doi-asserted-by":"crossref","first-page":"102916","DOI":"10.1016\/j.arcmed.2023.102916","volume":"55","author":"LG Balcazar-Ochoa","year":"2024","unstructured":"Balcazar-Ochoa LG, Ventura-Mart\u00ednez R, \u00c1ngeles-L\u00f3pez GE, G\u00f3mez-Acevedo C, Carrasco OF, Sampieri-Cabrera R, Chavarr\u00eda A, Gonz\u00e1lez-Hern\u00e1ndez A (2024) Clavulanic acid and its potential therapeutic effects on the central nervous system. Arch Med Res 55(1):102916","journal-title":"Arch Med Res"},{"issue":"7","key":"4566_CR44","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s11064-021-03308-y","volume":"46","author":"M Kolahdouz","year":"2021","unstructured":"Kolahdouz M, Jafari F, Falanji F, Nazemi S, Mohammadzadeh M, Molavi M, Amin B (2021) Clavulanic acid attenuating effect on the diabetic neuropathic pain in rats. Neurochem Res 46(7):1759\u20131770. https:\/\/doi.org\/10.1007\/s11064-021-03308-y","journal-title":"Neurochem Res"},{"issue":"4","key":"4566_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.32598\/bcn.10.4.799.2","volume":"10","author":"B Amin","year":"2019","unstructured":"Amin B, Avaznia M, Noorani R, Mehri S, Hosseinzadeh H (2019) Upregulation of glutamate transporter 1 by clavulanic acid administration and attenuation of allodynia and hyperalgesia in neuropathic rats. Basic Clin Neurosci 10(4):345\u2013354. https:\/\/doi.org\/10.32598\/bcn.10.4.799.2","journal-title":"Basic Clin Neurosci"},{"issue":"4","key":"4566_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.32598\/bcn.9.4.289","volume":"9","author":"S Mehri","year":"2018","unstructured":"Mehri S, Sajjadi SS, Tabatabai SM, Hosseinzadeh H (2018) Effects of clavulanic acid on the acquisition and reinstatement following morphine-induced conditioned place preference in mice. Basic Clin Neurosci 9(4):289\u2013296. https:\/\/doi.org\/10.32598\/bcn.9.4.289","journal-title":"Basic Clin Neurosci"},{"issue":"7021","key":"4566_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, et al (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433(7021):73\u201377. https:\/\/doi.org\/10.1038\/nature03180","journal-title":"Nature"},{"key":"4566_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2012.06.005","volume":"1469","author":"GC Kost","year":"2012","unstructured":"Kost GC, Selvaraj S, Lee YB, Kim DJ, Ahn CH, Singh BB (2012) Clavulanic acid inhibits MPP(+)-induced ROS generation and subsequent loss of dopaminergic cells. Brain Res 1469:129\u2013135. https:\/\/doi.org\/10.1016\/j.brainres.2012.06.005","journal-title":"Brain Res"},{"key":"4566_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drugalcdep.2014.05.012","volume":"142","author":"JA Schroeder","year":"2014","unstructured":"Schroeder JA, Tolman NG, McKenna FF, Watkins KL, Passeri SM, Hsu AH, Shinn BR, Rawls SM (2014) Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug? Drug Alcohol Depend 142:41\u201345. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.012","journal-title":"Drug Alcohol Depend"},{"issue":"21","key":"4566_CR50","doi-asserted-by":"crossref","first-page":"15657","DOI":"10.3390\/ijms242115657","volume":"24","author":"AO Arab","year":"2023","unstructured":"Arab AO, Alasmari F, Albaker AB, Alhazmi HA, Alameen AA, Alagail NM, Alwaeli SA, Rizwan Ahamad S, et al (2023) Clavulanic acid improves memory dysfunction and anxiety behaviors through upregulating glutamatergic transporters in the nucleus accumbens of mice repeatedly exposed to khat extract. Int J Mol Sci 24(21):15657","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4566_CR51","doi-asserted-by":"publisher","first-page":"13861","DOI":"10.1021\/acsomega.2c00231","volume":"7","author":"M Anoush","year":"2022","unstructured":"Anoush M, Pourmansouri Z, Javadi R, GhorbanPour B, Sharafi A, Mohamadpour H, Jafari Anarkooli I, Andalib S (2022) Clavulanic acid: a novel potential agent in prevention and treatment of scopolamine-induced Alzheimer\u2019s disease. ACS Omega 7(16):13861\u201313869. https:\/\/doi.org\/10.1021\/acsomega.2c00231","journal-title":"ACS Omega"},{"key":"4566_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2017.08.013","volume":"657","author":"AY Hakami","year":"2017","unstructured":"Hakami AY, Sari Y (2017) beta-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats. Neurosci Lett 657:140\u2013145. https:\/\/doi.org\/10.1016\/j.neulet.2017.08.013","journal-title":"Neurosci Lett"},{"issue":"6","key":"4566_CR53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ddr.20378","volume":"71","author":"Y Huh","year":"2010","unstructured":"Huh Y, Ju MS, Park H, Han S, Bang YM, Ferris CF, Koppell GA, King JA, Kim ML, Kim DJ (2010) Clavulanic acid protects neurons in pharmacological models of neurodegenerative diseases. Drug Dev Res 71(6):351\u2013357","journal-title":"Drug Dev Res"},{"issue":"4","key":"4566_CR54","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.pbb.2012.12.001","volume":"103","author":"F Sanna","year":"2013","unstructured":"Sanna F, Melis MR, Angioni L, Argiolas A (2013) Clavulanic acid induces penile erection and yawning in male rats: comparison with apomorphine. Pharmacol Biochem Behav 103(4):750\u2013755. https:\/\/doi.org\/10.1016\/j.pbb.2012.12.001","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20133","key":"4566_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejphar.2009.03.009","volume":"609","author":"JS Chan","year":"2009","unstructured":"Chan JS, Kim DJ, Ahn CH, Oosting RS, Olivier B (2009) Clavulanic acid stimulates sexual behaviour in male rats. Eur J Pharmacol 609(1\u20133):69\u201373. https:\/\/doi.org\/10.1016\/j.ejphar.2009.03.009","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4566_CR56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2011.09.032","volume":"504","author":"GC Kost","year":"2011","unstructured":"Kost GC, Selvaraj S, Lee YB, Kim DJ, Ahn C-H, Singh BB (2011) Clavulanic acid increases dopamine release in neuronal cells through a mechanism involving enhanced vesicle trafficking. Neurosci Lett 504(2):170\u2013175","journal-title":"Neurosci Lett"},{"issue":"7","key":"4566_CR57","first-page":"3312","volume":"3","author":"A Banani","year":"2012","unstructured":"Banani A, Maleki-Dizaji N, Garjani A, Soraya H, Mostafalou S, Ziaee M (2012) Clavulanic acid exhibits anti-inflammatory effects on carrageenan-induced paw edema model of inflammation in rats. Ann Biol Res 3(7):3312\u20133320","journal-title":"Ann Biol Res"},{"issue":"2","key":"4566_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/01480545.2018.1468772","volume":"42","author":"S Silakhori","year":"2019","unstructured":"Silakhori S, Hosseinzadeh H, Shaebani Behbahani F, Mehri S (2019) Neuroprotective effect of clavulanic acid on trimethyltin (TMT)-induced cytotoxicity in PC12 cells. Drug Chem Toxicol 42(2):187\u2013193. https:\/\/doi.org\/10.1080\/01480545.2018.1468772","journal-title":"Drug Chem Toxicol"},{"issue":"8","key":"4566_CR59","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/ddr.21595","volume":"80","author":"M Ghanbarabadi","year":"2019","unstructured":"Ghanbarabadi M, Falanji F, Rad A, Chazani Sharahi N, Amoueian S, Amin M, Molavi M, Amin B (2019) Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats. Drug Dev Res 80(8):1110\u20131119. https:\/\/doi.org\/10.1002\/ddr.21595","journal-title":"Drug Dev Res"},{"issue":"2","key":"4566_CR60","first-page":"32","volume":"5","author":"S Silakhori","year":"2017","unstructured":"Silakhori S, Hoseinzadeh H, Mehri S (2017) P 1: Effect of clavulanic acid on trimethyltin-induced cytotoxicity in PC12. The Neurosci J Shefaye Khatam 5(2):32\u201332","journal-title":"The Neurosci J Shefaye Khatam"},{"key":"4566_CR61","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/JPR.S154661","volume":"11","author":"A Ochoa-Aguilar","year":"2018","unstructured":"Ochoa-Aguilar A, Ventura-Martinez R, Sotomayor-Sobrino MA, Jaimez R, Coffeen U, Jimenez-Gonzalez A, Balcazar-Ochoa LG, Perez-Medina-Carballo R, Rodriguez R, Plancarte-Sanchez R (2018) Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model. J Pain Res 11:977\u2013985. https:\/\/doi.org\/10.2147\/JPR.S154661","journal-title":"J Pain Res"},{"issue":"6","key":"4566_CR62","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/fcp.12729","volume":"35","author":"CH Liu","year":"2021","unstructured":"Liu CH, Liao WC, Li HH, Tseng LH, Wang WH, Tung H, Lin PJ, Jao HT, et al (2021) Treatment with the combination of clavulanic acid and valproic acid led to recovery of neuronal and behavioral deficits in an epilepsy rat model. Fundam Clin Pharmacol 35(6):1032\u20131044. https:\/\/doi.org\/10.1111\/fcp.12729","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"4566_CR63","first-page":"376","volume":"5","author":"MR Khazdair","year":"2015","unstructured":"Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, Tsatsakis AM (2015) The effects of Crocus sativus (saffron) and its constituents on nervous system: a review. Avicenna J Phytomed 5(5):376\u2013391","journal-title":"Avicenna J Phytomed"},{"key":"4566_CR64","doi-asserted-by":"publisher","first-page":"8214821","DOI":"10.1155\/2022\/8214821","volume":"2022","author":"M Butnariu","year":"2022","unstructured":"Butnariu M, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Singh L, Aborehab NM, Bouyahya A, Venditti A, et al (2022) The pharmacological activities of Crocus sativus L.: a review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev 2022:8214821. https:\/\/doi.org\/10.1155\/2022\/8214821","journal-title":"Oxid Med Cell Longev"},{"key":"4566_CR65","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1002\/ptr.7583","volume":"36","author":"M Boozari","year":"2022","unstructured":"Boozari M, Hosseinzadeh H (2022) Crocin molecular signaling pathways at a glance: a comprehensive review. Phytother Res 36:3859","journal-title":"Phytother Res"},{"issue":"12","key":"4566_CR66","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1080\/10408398.2020.1864279","volume":"62","author":"D Cerda-Bernad","year":"2022","unstructured":"Cerda-Bernad D, Valero-Cases E, Pastor JJ, Frutos MJ (2022) Saffron bioactives crocin, crocetin and safranal: effect on oxidative stress and mechanisms of action. Crit Rev Food Sci Nutr 62(12):3232\u20133249. https:\/\/doi.org\/10.1080\/10408398.2020.1864279","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4566_CR67","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s11064-020-03134-8","volume":"45","author":"S Kermanshahi","year":"2020","unstructured":"Kermanshahi S, Ghanavati G, Abbasi-Mesrabadi M, Gholami M, Ulloa L, Motaghinejad M, Safari S (2020) Novel neuroprotective potential of crocin in neurodegenerative disorders: an illustrated mechanistic review. Neurochem Res 45:2573\u20132585","journal-title":"Neurochem Res"},{"key":"4566_CR68","doi-asserted-by":"crossref","first-page":"111521","DOI":"10.1016\/j.fct.2020.111521","volume":"143","author":"M Hashemzaei","year":"2020","unstructured":"Hashemzaei M, Mamoulakis C, Tsarouhas K, Georgiadis G, Lazopoulos G, Tsatsakis A, Asrami ES, Rezaee R (2020) Crocin: a fighter against inflammation and pain. Food Chem Toxicol 143:111521","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"4566_CR69","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/biof.1557","volume":"45","author":"S Korani","year":"2019","unstructured":"Korani S, Korani M, Sathyapalan T, Sahebkar A (2019) Therapeutic effects of crocin in autoimmune diseases: a review. BioFactors 45(6):835\u2013843","journal-title":"BioFactors"},{"issue":"2","key":"4566_CR70","first-page":"745","volume":"18","author":"S Mozaffari","year":"2019","unstructured":"Mozaffari S, Yasuj SR, Motaghinejad M, Motevalian M, Kheiri R (2019) Crocin acting as a neuroprotective agent against methamphetamine-induced neurodegeneration via CREB-BDNF signaling pathway. Iranian J Pharm Res: IJPR 18(2):745","journal-title":"Iranian J Pharm Res: IJPR"},{"key":"4566_CR71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2019.01.017","volume":"124","author":"M Motaghinejad","year":"2019","unstructured":"Motaghinejad M, Safari S, Feizipour S, Sadr S (2019) Crocin may be useful to prevent or treatment of alcohol induced neurodegeneration and neurobehavioral sequels via modulation of CREB\/BDNF and Akt\/GSK signaling pathway. Med Hypotheses 124:21\u201325","journal-title":"Med Hypotheses"},{"key":"4566_CR72","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.biopha.2018.01.113","volume":"99","author":"G Akbari","year":"2018","unstructured":"Akbari G, Ali mard S, Veisi A (2018) A comprehensive review on regulatory effects of crocin on ischemia\/reperfusion injury in multiple organs. Biomed Pharma 99:664\u2013670","journal-title":"Biomed Pharma"},{"issue":"7","key":"4566_CR73","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ptr.5622","volume":"30","author":"MH Boskabady","year":"2016","unstructured":"Boskabady MH, Farkhondeh T (2016) Antiinflammatory, antioxidant, and immunomodulatory effects of Crocus sativus L. and its main constituents. Phytother Res 30(7):1072\u20131094","journal-title":"Phytother Res"},{"issue":"12","key":"4566_CR74","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s11064-018-2644-2","volume":"43","author":"M Shafahi","year":"2018","unstructured":"Shafahi M, Vaezi G, Shajiee H, Sharafi S, Khaksari M (2018) Crocin inhibits apoptosis and astrogliosis of hippocampus neurons against methamphetamine neurotoxicity via antioxidant and anti-inflammatory mechanisms. Neurochem Res 43(12):2252\u20132259. https:\/\/doi.org\/10.1007\/s11064-018-2644-2","journal-title":"Neurochem Res"},{"issue":"1\u20133","key":"4566_CR75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2010.09.003","volume":"648","author":"KN Nam","year":"2010","unstructured":"Nam KN, Park Y-M, Jung H-J, Lee JY, Min BD, Park S-U, Jung W-S, Cho K-H, et al (2010) Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol 648(1\u20133):110\u2013116","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4566_CR76","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3892\/ijmm.2018.4032","volume":"43","author":"C Wang","year":"2019","unstructured":"Wang C, Cai X, Hu W, Li Z, Kong F, Chen X, Wang D (2019) Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer\u2019s disease. Int J Mol Med 43(2):956\u2013966. https:\/\/doi.org\/10.3892\/ijmm.2018.4032","journal-title":"Int J Mol Med"},{"issue":"7","key":"4566_CR77","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3390\/molecules27072076","volume":"27","author":"SA Siddiqui","year":"2022","unstructured":"Siddiqui SA, Ali Redha A, Snoeck ER, Singh S, Simal-Gandara J, Ibrahim SA, Jafari SM (2022) Anti-depressant properties of crocin molecules in saffron. Molecules 27(7):2076","journal-title":"Molecules"},{"key":"4566_CR78","doi-asserted-by":"publisher","unstructured":"Ettehadi H, Mojabi SN, Ranjbaran M, Shams J, Sahraei H, Hedayati M, Asefi F (2013) Aqueous extract of saffron (Crocus sativus) increases brain dopamine and glutamate concentrations in rats. https:\/\/doi.org\/10.4236\/jbbs.2013.33031","DOI":"10.4236\/jbbs.2013.33031"},{"issue":"11","key":"4566_CR79","first-page":"48","volume":"3","author":"H Hosseinzadeh","year":"2004","unstructured":"Hosseinzadeh H, Karimi G, Niapoor M (2004) Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. Journal of Medicinal Plants 3(11):48\u201358","journal-title":"Journal of Medicinal Plants"},{"key":"4566_CR80","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1007\/s12035-020-01941-2","volume":"57","author":"J Tang","year":"2020","unstructured":"Tang J, Lu L, Wang Q, Liu H, Xue W, Zhou T, Xu L, Wang K, et al (2020) Crocin reverses depression-like behavior in Parkinson disease mice via VTA-mPFC pathway. Mol Neurobiol 57:3158\u20133170","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4566_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.acthis.2018.12.003","volume":"121","author":"L Tamegart","year":"2019","unstructured":"Tamegart L, Abbaoui A, Makbal R, Zroudi M, Bouizgarne B, Bouyatas MM, Gamrani H (2019) Crocus sativus restores dopaminergic and noradrenergic damages induced by lead in Meriones shawi: a possible link with Parkinson\u2019s disease. Acta Histochem 121(2):171\u2013181. https:\/\/doi.org\/10.1016\/j.acthis.2018.12.003","journal-title":"Acta Histochem"},{"issue":"10","key":"4566_CR82","first-page":"1070","volume":"19","author":"M Kamyar","year":"2016","unstructured":"Kamyar M, Razavi BM, Hasani FV, Mehri S, Foroutanfar A, Hosseinzadeh H (2016) Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism. Iran J Basic Med Sci 19(10):1070\u20131079","journal-title":"Iran J Basic Med Sci"},{"issue":"11","key":"4566_CR83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41684-021-00871-3","volume":"50","author":"S Ahmadi-Noorbakhsh","year":"2021","unstructured":"Ahmadi-Noorbakhsh S, Mirabzadeh Ardakani E, Sadighi J, Aldavood SJ, Farajli Abbasi M, Farzad-Mohajeri S, Ghasemi A, Sharif-Paghaleh E, et al (2021) Guideline for the care and use of laboratory animals in Iran. Lab Anim 50(11):303\u2013305","journal-title":"Lab Anim"},{"key":"4566_CR84","unstructured":"Institute of Laboratory Animal Resources (US). Committee on Care and Use of Laboratory Animals (1986) Guide for the care and use of laboratory animals. No. 86. US Department of Health and Human Services, Public Health Service, National Institutes of Health"},{"issue":"1","key":"4566_CR85","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1002\/cpns.68","volume":"88","author":"FP Guzen","year":"2019","unstructured":"Guzen FP, Cavalcanti J, Cavalcanti D, de Sales LGP, da Silva MSM, da Silva ANA, Pinheiro FI, de Araujo DP (2019) Haloperidol-induced preclinical tardive dyskinesia model in rats. Curr Protoc Neurosci 88(1):e68. https:\/\/doi.org\/10.1002\/cpns.68","journal-title":"Curr Protoc Neurosci"},{"issue":"5","key":"4566_CR86","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1007\/s11356-017-0842-0","volume":"25","author":"L Mohammadzadeh","year":"2018","unstructured":"Mohammadzadeh L, Hosseinzadeh H, Abnous K, Razavi BM (2018) Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats. Environ Sci Pollut Res Int 25(5):4904\u20134914. https:\/\/doi.org\/10.1007\/s11356-017-0842-0","journal-title":"Environ Sci Pollut Res Int"},{"key":"4566_CR87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00240-014-0711-y","volume":"42","author":"FA Ghaeni","year":"2014","unstructured":"Ghaeni FA, Amin B, Hariri AT, Meybodi NT, Hosseinzadeh H (2014) Antilithiatic effects of crocin on ethylene glycol-induced lithiasis in rats. Urolithiasis 42:549\u2013558","journal-title":"Urolithiasis"},{"key":"4566_CR88","doi-asserted-by":"crossref","unstructured":"da Cunha Germano BC, de Morais LCC, Idalina Neta F, Fernandes ACL, Pinheiro FI, do Rego ACM, Ara\u00fajo Filho I, de Azevedo EP, et al (2023) Vitamin E and its molecular effects in experimental models of neurodegenerative diseases. Int J Mol Sci 24 (13):11191","DOI":"10.3390\/ijms241311191"},{"issue":"4","key":"4566_CR89","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-2605.2004.00476.x","volume":"27","author":"K Cam","year":"2004","unstructured":"Cam K, Simsek F, Yuksel M, Turkeri L, Haklar G, Yalcin S, Akdas A (2004) The role of reactive oxygen species and apoptosis in the pathogenesis of varicocele in a rat model and efficiency of vitamin E treatment. Int J Androl 27(4):228\u2013233. https:\/\/doi.org\/10.1111\/j.1365-2605.2004.00476.x","journal-title":"Int J Androl"},{"key":"4566_CR90","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/B978-0-12-381328-2.00011-0","volume":"98","author":"SK Kulkarni","year":"2011","unstructured":"Kulkarni SK, Dhir A (2011) Animal models of tardive dyskinesia. Int Rev Neurobiol 98:265\u2013287. https:\/\/doi.org\/10.1016\/B978-0-12-381328-2.00011-0","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"4566_CR91","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00213-003-1428-8","volume":"167","author":"PS Naidu","year":"2003","unstructured":"Naidu PS, Singh A, Kulkarni SK (2003) Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid. Psychopharmacology 167(4):418\u2013423. https:\/\/doi.org\/10.1007\/s00213-003-1428-8","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"4566_CR92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1\u20133):3\u201333","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4566_CR93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14(3):149\u2013167","journal-title":"J Neurosci Methods"},{"issue":"2","key":"4566_CR94","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"issue":"1","key":"4566_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582(1):67\u201378. https:\/\/doi.org\/10.1016\/0304-4165(79)90289-7","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"4566_CR96","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1042\/bj0940705","volume":"94","author":"CW Owens","year":"1965","unstructured":"Owens CW, Belcher RV (1965) A colorimetric micro-method for the determination of glutathione. Biochem J 94(3):705\u2013711. https:\/\/doi.org\/10.1042\/bj0940705","journal-title":"Biochem J"},{"issue":"4","key":"4566_CR97","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/ptr.6944","volume":"35","author":"M Fadishei","year":"2021","unstructured":"Fadishei M, Ghasemzadeh Rahbardar M, Imenshahidi M, Mohajeri A, Razavi BM, Hosseinzadeh H (2021) Effects of Nigella sativa oil and thymoquinone against bisphenol A-induced metabolic disorder in rats. Phytother Res 35(4):2005\u20132024. https:\/\/doi.org\/10.1002\/ptr.6944","journal-title":"Phytother Res"},{"issue":"2","key":"4566_CR98","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ptr.6861","volume":"35","author":"MS Mohsenzadeh","year":"2021","unstructured":"Mohsenzadeh MS, Razavi BM, Imenshahidi M, Mohajeri SA, Rameshrad M, Hosseinzadeh H (2021) Evaluation of green tea extract and epigallocatechin gallate effects on bisphenol A-induced vascular toxicity in isolated rat aorta and cytotoxicity in human umbilical vein endothelial cells. Phytother Res 35(2):996\u20131009. https:\/\/doi.org\/10.1002\/ptr.6861","journal-title":"Phytother Res"},{"issue":"1","key":"4566_CR99","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1744-9081-8-12","volume":"8","author":"PJ Blanchet","year":"2012","unstructured":"Blanchet PJ, Parent MT, Rompre PH, Levesque D (2012) Relevance of animal models to human tardive dyskinesia. Behav Brain Funct 8(1):12. https:\/\/doi.org\/10.1186\/1744-9081-8-12","journal-title":"Behav Brain Funct"},{"key":"4566_CR100","first-page":"305","volume":"24","author":"SD Iversen","year":"1980","unstructured":"Iversen SD, Howells RB, Hughes RP (1980) Behavioral consequences of long-term treatment with neuroleptic drugs. Adv Biochem Psychopharmacol 24:305\u2013313","journal-title":"Adv Biochem Psychopharmacol"},{"issue":"1","key":"4566_CR101","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF00426516","volume":"69","author":"RB Glassman","year":"1980","unstructured":"Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69(1):19\u201325. https:\/\/doi.org\/10.1007\/BF00426516","journal-title":"Psychopharmacology"},{"issue":"3","key":"4566_CR102","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/npp.2008.116","volume":"34","author":"N Ginovart","year":"2009","unstructured":"Ginovart N, Wilson AA, Hussey D, Houle S, Kapur S (2009) D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats. Neuropsychopharmacology 34(3):662\u2013671","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"4566_CR103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2008.01.010","volume":"64","author":"A-N Samaha","year":"2008","unstructured":"Samaha A-N, Reckless GE, Seeman P, Diwan M, Nobrega JN, Kapur S (2008) Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery. Biol Psychiat 64(2):145\u2013152","journal-title":"Biol Psychiat"},{"issue":"4","key":"4566_CR104","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF02247127","volume":"102","author":"CA Tamminga","year":"1990","unstructured":"Tamminga CA, Dale J, Goodman L, Kaneda H, Kaneda N (1990) Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102(4):474\u2013478","journal-title":"Psychopharmacology"},{"issue":"11","key":"4566_CR105","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1007\/s11064-022-03677-y","volume":"47","author":"A Kadir","year":"2022","unstructured":"Kadir A, Singh J, Rahi V, Kumar P (2022) Berberine ameliorate haloperidol and 3-nitropropionic acid-induced neurotoxicity in rats. Neurochem Res 47(11):3285\u20133297. https:\/\/doi.org\/10.1007\/s11064-022-03677-y","journal-title":"Neurochem Res"},{"issue":"3","key":"4566_CR106","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12640-021-00333-1","volume":"39","author":"MH Wang","year":"2021","unstructured":"Wang MH, Yang CC, Tseng HC, Fang CH, Lin YW, Soung HS (2021) Naringin ameliorates haloperidol-induced neurotoxicity and orofacial dyskinesia in a rat model of human tardive dyskinesia. Neurotox Res 39(3):774\u2013786. https:\/\/doi.org\/10.1007\/s12640-021-00333-1","journal-title":"Neurotox Res"},{"key":"4566_CR107","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","volume":"74","author":"AB Sonego","year":"2018","unstructured":"Sonego AB, Prado DS, Vale GT, Sepulveda-Diaz JE, Cunha TM, Tirapelli CR, Del Bel EA, Raisman-Vozari R, et al (2018) Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARgamma receptors. Brain Behav Immun 74:241\u2013251. https:\/\/doi.org\/10.1016\/j.bbi.2018.09.014","journal-title":"Brain Behav Immun"},{"key":"4566_CR108","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2015.12.032","volume":"771","author":"S Datta","year":"2016","unstructured":"Datta S, Jamwal S, Deshmukh R, Kumar P (2016) Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: possible neurotransmitters and neuroinflammation modulation. Eur J Pharmacol 771:229\u2013235. https:\/\/doi.org\/10.1016\/j.ejphar.2015.12.032","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"4566_CR109","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/s0028-3908(03)00101-1","volume":"44","author":"PS Naidu","year":"2003","unstructured":"Naidu PS, Singh A, Kulkarni SK (2003) Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 44(8):1100\u20131106. https:\/\/doi.org\/10.1016\/s0028-3908(03)00101-1","journal-title":"Neuropharmacology"},{"issue":"4","key":"4566_CR110","first-page":"167","volume":"57","author":"JB Lohr","year":"1996","unstructured":"Lohr JB, Caligiuri MP (1996) A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 57(4):167\u2013173","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"4566_CR111","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/s0006-3223(99)00091-8","volume":"46","author":"P Sachdev","year":"1999","unstructured":"Sachdev P, Saharov T, Cathcart S (1999) The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia. Biol Psychiatry 46(12):1672\u20131681. https:\/\/doi.org\/10.1016\/s0006-3223(99)00091-8","journal-title":"Biol Psychiatry"},{"issue":"4","key":"4566_CR112","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00004850-199807000-00001","volume":"13","author":"SH Sajjad","year":"1998","unstructured":"Sajjad SH (1998) Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses. Int Clin Psychopharmacol 13(4):147\u2013155. https:\/\/doi.org\/10.1097\/00004850-199807000-00001","journal-title":"Int Clin Psychopharmacol"},{"key":"4566_CR113","doi-asserted-by":"publisher","unstructured":"Soares-Weiser K, Maayan N, McGrath J (2011) Vitamin E for antipsychotic\u2010induced tardive dyskinesia. Cochrane Database Syst Rev 2011 (2). https:\/\/doi.org\/10.1002\/14651858.CD000209.pub2","DOI":"10.1002\/14651858.CD000209.pub2"},{"issue":"1","key":"4566_CR114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/01.jcp.0000104912.75206.2b","volume":"24","author":"XY Zhang","year":"2004","unstructured":"Zhang XY, Zhou DF, Cao LY, Xu CQ, Chen DC, Wu GY (2004) The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial. J Clin Psychopharmacol 24(1):83\u201386. https:\/\/doi.org\/10.1097\/01.jcp.0000104912.75206.2b","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"4566_CR115","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.pbb.2007.10.009","volume":"88","author":"M Bishnoi","year":"2008","unstructured":"Bishnoi M, Chopra K, Kulkarni SK (2008) Protective effect of curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav 88(4):511\u2013522. https:\/\/doi.org\/10.1016\/j.pbb.2007.10.009","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"4566_CR116","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.wnf.0000191331.54649.e3","volume":"28","author":"O Sadan","year":"2005","unstructured":"Sadan O, Bahat-Stromza M, Gilgun-Sherki Y, Atlas D, Melamed E, Offen D (2005) A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: implications for tardive dyskinesia. Clin Neuropharmacol 28(6):285\u2013288. https:\/\/doi.org\/10.1097\/01.wnf.0000191331.54649.e3","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"4566_CR117","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(71)90087-6","volume":"14","author":"HL Klawans","year":"1971","unstructured":"Klawans HL, McKendall RR (1971) Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia. J Neurol Sci 14(2):189\u2013192. https:\/\/doi.org\/10.1016\/0022-510X(71)90087-6","journal-title":"J Neurol Sci"},{"issue":"3","key":"4566_CR118","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF01245320","volume":"33","author":"HL Klawans Jr","year":"1972","unstructured":"Klawans HL Jr, Rubovits R (1972) An experimental model of tardive dyskinesia. J Neural Transm 33(3):235\u2013246. https:\/\/doi.org\/10.1007\/BF01245320","journal-title":"J Neural Transm"},{"issue":"1","key":"4566_CR119","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/s003329170003960x","volume":"10","author":"CD Marsden","year":"1980","unstructured":"Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10(1):55\u201372. https:\/\/doi.org\/10.1017\/s003329170003960x","journal-title":"Psychol Med"},{"issue":"2","key":"4566_CR120","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0922-4106(91)90092-v","volume":"207","author":"P Rogue","year":"1991","unstructured":"Rogue P, Hanauer A, Zwiller J, Malviya AN, Vincendon G (1991) Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment. Eur J Pharmacol 207(2):165\u2013168. https:\/\/doi.org\/10.1016\/0922-4106(91)90092-v","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 9","key":"4566_CR121","first-page":"25","volume":"65","author":"DE Casey","year":"2004","unstructured":"Casey DE (2004) Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 65(Suppl 9):25\u201328","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"4566_CR122","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/1097-0185(20001201)260:4<378::AID-AR70>3.0.CO;2-A","volume":"260","author":"JR McClung","year":"2000","unstructured":"McClung JR, Goldberg SJ (2000) Functional anatomy of the hypoglossal innervated muscles of the rat tongue: a model for elongation and protrusion of the mammalian tongue. Anatomical Record: An Off Publ Am Assoc Anatomists 260(4):378\u2013386","journal-title":"Anatomical Record: An Off Publ Am Assoc Anatomists"},{"issue":"1","key":"4566_CR123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1096-3642.1971.tb00752.x","volume":"50","author":"K Hiiemae","year":"1971","unstructured":"Hiiemae K, Houston W (1971) The structure and function of the jaw muscles in the rat (Rattus norvegicus L.) I. Their anatomy and internal architecture. Zool J Linnean Soc 50(1):75\u201399","journal-title":"Zool J Linnean Soc"},{"issue":"4","key":"4566_CR124","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0091-3057(97)00510-8","volume":"59","author":"F Hall","year":"1998","unstructured":"Hall F, Wilkinson LS, Humby T, Inglis W, Kendall D, Marsden C, Robbins T (1998) Isolation rearing in rats: pre-and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav 59(4):859\u2013872","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"4566_CR125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-5198(19)36218-3","volume":"21","author":"B Gupta","year":"1971","unstructured":"Gupta B, Dandiya P, Gupta M (1971) A psycho-pharmacological analysis of behaviour in rats. Jpn J Pharmacol 21(3):293\u2013298","journal-title":"Jpn J Pharmacol"},{"key":"4566_CR126","doi-asserted-by":"crossref","first-page":"113652","DOI":"10.1016\/j.physbeh.2021.113652","volume":"244","author":"M Ghafarimoghadam","year":"2022","unstructured":"Ghafarimoghadam M, Mashayekh R, Gholami M, Fereydani P, Shelley-Tremblay J, Kandezi N, Sabouri E, Motaghinejad M (2022) A review of behavioral methods for the evaluation of cognitive performance in animal models: current techniques and links to human cognition. Physiol Behav 244:113652","journal-title":"Physiol Behav"},{"issue":"11","key":"4566_CR127","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/ejn.15222","volume":"53","author":"I Waku","year":"2021","unstructured":"Waku I, Magalhaes MS, Alves CO, de Oliveira AR (2021) Haloperidol-induced catalepsy as an animal model for parkinsonism: a systematic review of experimental studies. Eur J Neurosci 53(11):3743\u20133767","journal-title":"Eur J Neurosci"},{"issue":"3","key":"4566_CR128","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(73)90028-9","volume":"22","author":"H Asper","year":"1973","unstructured":"Asper H, Baggiolini M, Burki HR, Lauener H, Ruch W, Stille G (1973) Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur J Pharmacol 22(3):287\u2013294. https:\/\/doi.org\/10.1016\/0014-2999(73)90028-9","journal-title":"Eur J Pharmacol"},{"key":"4566_CR129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fnsys.2013.00110","volume":"7","author":"D Yael","year":"2013","unstructured":"Yael D, Zeef DH, Sand D, Moran A, Katz DB, Cohen D, Temel Y, Bar-Gad I (2013) Haloperidol-induced changes in neuronal activity in the striatum of the freely moving rat. Front Syst Neurosci 7:110","journal-title":"Front Syst Neurosci"},{"key":"4566_CR130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnagi.2014.00087","volume":"6","author":"A Benazzouz","year":"2014","unstructured":"Benazzouz A, Mamad O, Abedi P, Bouali-Benazzouz R, Chetrit J (2014) Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson\u2019s disease. Front Aging Neurosci 6:87","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"4566_CR131","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biomedicines10030542","volume":"10","author":"M Decourt","year":"2022","unstructured":"Decourt M, Balado E, Jimenez-Urbieta H, Francheteau M, Fernagut PO, Benoit-Marand M (2022) Assessment of repetitive and compulsive behaviors induced by pramipexole in rats: effect of alpha-synuclein-induced nigrostriatal degeneration. Biomedicines 10(3):542. https:\/\/doi.org\/10.3390\/biomedicines10030542","journal-title":"Biomedicines"},{"issue":"2","key":"4566_CR132","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0166-4328(93)90121-6","volume":"55","author":"G Mittleman","year":"1993","unstructured":"Mittleman G, LeDuc PA, Whishaw IQ (1993) The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia. Behav Brain Res 55(2):253\u2013267. https:\/\/doi.org\/10.1016\/0166-4328(93)90121-6","journal-title":"Behav Brain Res"},{"key":"4566_CR133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pnpbp.2016.07.002","volume":"71","author":"M Uys","year":"2016","unstructured":"Uys M, Shahid M, Sallinen J, Dreyer W, Cockeran M, Harvey BH (2016) The \u03b12C-adrenoceptor antagonist, ORM-10921, has antipsychotic-like effects in social isolation reared rats and bolsters the response to haloperidol. Prog Neuropsychopharmacol Biol Psychiatry 71:108\u2013116","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"4566_CR134","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","volume":"184","author":"B Grayson","year":"2007","unstructured":"Grayson B, Idris NF, Neill JC (2007) Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res 184(1):31\u201338. https:\/\/doi.org\/10.1016\/j.bbr.2007.06.012","journal-title":"Behav Brain Res"},{"key":"4566_CR135","unstructured":"Gerriets LRUV (2023) Clavulanic acid. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545273"},{"issue":"5","key":"4566_CR136","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s11011-019-00451-y","volume":"34","author":"SV Rao","year":"2019","unstructured":"Rao SV, Hemalatha P, Yetish S, Muralidhara M, Rajini PS (2019) Prophylactic neuroprotective propensity of crocin, a carotenoid against rotenone induced neurotoxicity in mice: Behavioural and biochemical evidence. Metab Brain Dis 34(5):1341\u20131353. https:\/\/doi.org\/10.1007\/s11011-019-00451-y","journal-title":"Metab Brain Dis"},{"key":"4566_CR137","doi-asserted-by":"publisher","unstructured":"Fatemi R, Fathimoghadam H, Ghadiri A, Farbod Y (2022) Effects of crocin on brain neurotrophins, cognition, sensory and motor dysfunction in rats demyelination with ethidium bromide.\u00a0https:\/\/doi.org\/10.20944\/preprints202208.0161.v1","DOI":"10.20944\/preprints202208.0161.v1"},{"issue":"2","key":"4566_CR138","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2(2):322\u2013328","journal-title":"Nat Protoc"},{"issue":"6","key":"4566_CR139","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/s0149-7634(96)00058-9","volume":"21","author":"RJ Rodgers","year":"1997","unstructured":"Rodgers RJ, Dalvi A (1997) Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21(6):801\u2013810. https:\/\/doi.org\/10.1016\/s0149-7634(96)00058-9","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"4566_CR140","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF02244851","volume":"114","author":"JC Cole","year":"1994","unstructured":"Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114(2):288\u2013296. https:\/\/doi.org\/10.1007\/BF02244851","journal-title":"Psychopharmacology"},{"issue":"4","key":"4566_CR141","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0091-3057(94)90253-4","volume":"49","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers RJ, Nikulina EM, Cole JC (1994) Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 49(4):985\u2013995. https:\/\/doi.org\/10.1016\/0091-3057(94)90253-4","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"4566_CR142","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0892-0362(02)00189-7","volume":"24","author":"KP Singh","year":"2002","unstructured":"Singh KP, Singh M (2002) Effect of prenatal haloperidol exposure on behavioral alterations in rats. Neurotoxicol Teratol 24(4):497\u2013502. https:\/\/doi.org\/10.1016\/s0892-0362(02)00189-7","journal-title":"Neurotoxicol Teratol"},{"key":"4566_CR143","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jad.2017.11.020","volume":"227","author":"M Shafiee","year":"2018","unstructured":"Shafiee M, Arekhi S, Omranzadeh A, Sahebkar A (2018) Saffron in the treatment of depression, anxiety and other mental disorders: current evidence and potential mechanisms of action. J Affect Disord 227:330\u2013337. https:\/\/doi.org\/10.1016\/j.jad.2017.11.020","journal-title":"J Affect Disord"},{"issue":"23","key":"4566_CR144","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.3390\/molecules25235647","volume":"25","author":"N Pitsikas","year":"2020","unstructured":"Pitsikas N, Tarantilis PA (2020) The GABAA-benzodiazepine receptor antagonist flumazenil abolishes the anxiolytic effects of the active constituents of Crocus sativus L. crocins in rats. Molecules 25(23):5647","journal-title":"Molecules"},{"issue":"6","key":"4566_CR145","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/ptr.2597","volume":"23","author":"H Hosseinzadeh","year":"2009","unstructured":"Hosseinzadeh H, Noraei NB (2009) Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 23(6):768\u2013774. https:\/\/doi.org\/10.1002\/ptr.2597","journal-title":"Phytother Res"},{"issue":"6","key":"4566_CR146","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00002826-199112000-00009","volume":"14","author":"J De Keyser","year":"1991","unstructured":"De Keyser J (1991) Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia. Clin Neuropharmacol 14(6):562\u2013565. https:\/\/doi.org\/10.1097\/00002826-199112000-00009","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"4566_CR147","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","volume":"78","author":"M Polydoro","year":"2004","unstructured":"Polydoro M, Schroder N, Lima MN, Caldana F, Laranja DC, Bromberg E, Roesler R, Quevedo J, et al (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 78(4):751\u2013756. https:\/\/doi.org\/10.1016\/j.pbb.2004.05.018","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"4566_CR148","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","volume":"372","author":"A Reinke","year":"2004","unstructured":"Reinke A, Martins MR, Lima MS, Moreira JC, Dal-Pizzol F, Quevedo J (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett 372(1\u20132):157\u2013160. https:\/\/doi.org\/10.1016\/j.neulet.2004.09.032","journal-title":"Neurosci Lett"},{"issue":"7","key":"4566_CR149","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0006-3223(94)90648-3","volume":"36","author":"BN Pai","year":"1994","unstructured":"Pai BN, Janakiramaiah N, Gangadhar BN, Ravindranath V (1994) Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration. Biol Psychiatry 36(7):489\u2013491. https:\/\/doi.org\/10.1016\/0006-3223(94)90648-3","journal-title":"Biol Psychiatry"},{"issue":"2","key":"4566_CR150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0006-8993(92)91058-M","volume":"595","author":"BR Shivakumar","year":"1992","unstructured":"Shivakumar BR, Ravindranath V (1992) Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol. Brain Res 595(2):256\u2013262","journal-title":"Brain Res"},{"issue":"3","key":"4566_CR151","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.psychres.2013.08.035","volume":"210","author":"M Boskovic","year":"2013","unstructured":"Boskovic M, Grabnar I, Terzic T, Kores Plesnicar B, Vovk T (2013) Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate. Psychiatry Res 210(3):761\u2013768. https:\/\/doi.org\/10.1016\/j.psychres.2013.08.035","journal-title":"Psychiatry Res"},{"issue":"14","key":"4566_CR152","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2174\/13895575113136660100","volume":"13","author":"M Raudenska","year":"2013","unstructured":"Raudenska M, Gumulec J, Babula P, Stracina T, Sztalmachova M, Polanska H, Adam V, Kizek R, et al (2013) Haloperidol cytotoxicity and its relation to oxidative stress. Mini Rev Med Chem 13(14):1993\u20131998. https:\/\/doi.org\/10.2174\/13895575113136660100","journal-title":"Mini Rev Med Chem"},{"issue":"6","key":"4566_CR153","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s0022-3956(98)00028-4","volume":"32","author":"JK Yao","year":"1998","unstructured":"Yao JK, Reddy R, McElhinny LG, van Kammen DP (1998) Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res 32(6):385\u2013391. https:\/\/doi.org\/10.1016\/s0022-3956(98)00028-4","journal-title":"J Psychiatr Res"},{"issue":"11","key":"4566_CR154","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0706743718786702","volume":"63","author":"T Pringsheim","year":"2018","unstructured":"Pringsheim T, Barnes TR (2018) Antipsychotic drug-induced movement disorders: a forgotten problem? Can J Psychiatry 63(11):717\u2013718","journal-title":"Can J Psychiatry"},{"issue":"4","key":"4566_CR155","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/1470320313515038","volume":"16","author":"KS Thakur","year":"2015","unstructured":"Thakur KS, Prakash A, Bisht R, Bansal PK (2015) Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat. J Renin Angiotensin Aldosterone Syst 16(4):917\u2013929. https:\/\/doi.org\/10.1177\/1470320313515038","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"4566_CR156","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2045-3701-1-12","volume":"1","author":"J Perera","year":"2011","unstructured":"Perera J, Tan JH, Jeevathayaparan S, Chakravarthi S, Haleagrahara N (2011) Neuroprotective effects of alpha lipoic acid on haloperidol-induced oxidative stress in the rat brain. Cell Biosci 1(1):12. https:\/\/doi.org\/10.1186\/2045-3701-1-12","journal-title":"Cell Biosci"},{"issue":"3","key":"4566_CR157","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/1028415X.2018.1492772","volume":"23","author":"L Mohammadzadeh","year":"2020","unstructured":"Mohammadzadeh L, Abnous K, Razavi BM, Hosseinzadeh H (2020) Crocin-protected malathion-induced spatial memory deficits by inhibiting TAU protein hyperphosphorylation and antiapoptotic effects. Nutr Neurosci 23(3):221\u2013236. https:\/\/doi.org\/10.1080\/1028415X.2018.1492772","journal-title":"Nutr Neurosci"},{"issue":"4","key":"4566_CR158","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21307\/ane-2019-033","volume":"79","author":"A Ebrahimzadeh","year":"2019","unstructured":"Ebrahimzadeh A, Moghadam S, Rahimi H, Motaghinejad M, Motevalian M, Safari S, Mesrabadi M (2019) Crocin acts as a neuroprotective mediator against methylphenidate-induced neurobehavioral and neurochemical sequelae: possible role of the CREB-BDNF signaling pathway. Acta Neurobiol Exp 79(4):352\u2013366","journal-title":"Acta Neurobiol Exp"},{"issue":"11","key":"4566_CR159","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.22038\/IJBMS.2017.9541","volume":"20","author":"S Heidari","year":"2017","unstructured":"Heidari S, Mehri S, Hosseinzadeh H (2017) Memory enhancement and protective effects of crocin against D-galactose aging model in the hippocampus of Wistar rats. Iran J Basic Med Sci 20(11):1250\u20131259. https:\/\/doi.org\/10.22038\/IJBMS.2017.9541","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"4566_CR160","doi-asserted-by":"crossref","first-page":"e01213","DOI":"10.1016\/j.heliyon.2019.e01213","volume":"5","author":"H Fathimoghadam","year":"2019","unstructured":"Fathimoghadam H, Farbod Y, Ghadiri A, Fatemi R (2019) Moderating effects of crocin on some stress oxidative markers in rat brain following demyelination with ethidium bromide. Heliyon 5(2):e01213","journal-title":"Heliyon"},{"issue":"1","key":"4566_CR161","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cell.2011.02.034","volume":"145","author":"F Edlich","year":"2011","unstructured":"Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C, Neutzner A, Tjandra N, et al (2011) Bcl-xL retrotranslocates Bax from the mitochondria into the cytosol. Cell 145(1):104\u2013116","journal-title":"Cell"},{"key":"4566_CR162","doi-asserted-by":"crossref","first-page":"9730467","DOI":"10.1155\/2016\/9730467","volume":"2016","author":"H Ju\u00e1rez Olgu\u00edn","year":"2016","unstructured":"Ju\u00e1rez Olgu\u00edn H, Calder\u00f3n Guzm\u00e1n D, Hern\u00e1ndez Garc\u00eda E, Barrag\u00e1n Mej\u00eda G (2016) The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxidative Med Cell 2016:9730467","journal-title":"Oxidative Med Cell"},{"key":"4566_CR163","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.fct.2017.03.020","volume":"103","author":"C-Y Lin","year":"2017","unstructured":"Lin C-Y, Fu R-H, Chou R-H, Chen J-H, Wu C-R, Chang S-W, Tsai C-W (2017) Inhibition of JNK by pi class of glutathione S-transferase through PKA\/CREB pathway is associated with carnosic acid protection against 6-hydroxydopamine-induced apoptosis. Food Chem Toxicol 103:194\u2013202","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4566_CR164","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0306-4522(01)00455-9","volume":"109","author":"IJ Mitchell","year":"2002","unstructured":"Mitchell IJ, Cooper AC, Griffiths MR, Cooper AJ (2002) Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat. Neuroscience 109(1):89\u201399. https:\/\/doi.org\/10.1016\/s0306-4522(01)00455-9","journal-title":"Neuroscience"},{"issue":"4","key":"4566_CR165","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.tpj.6500373","volume":"6","author":"Z Wei","year":"2006","unstructured":"Wei Z, Mousseau DD, Dai Y, Cao X, Li XM (2006) Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS. Pharmacogenomics J 6(4):279\u2013288. https:\/\/doi.org\/10.1038\/sj.tpj.6500373","journal-title":"Pharmacogenomics J"},{"issue":"13","key":"4566_CR166","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.phymed.2016.10.009","volume":"23","author":"HM An","year":"2016","unstructured":"An HM, Tan YL, Shi J, Wang Z, Lv MH, Soares JC, Zhou D, Yang F, Zhang XY (2016) Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation. Phytomedicine 23(13):1653\u20131660. https:\/\/doi.org\/10.1016\/j.phymed.2016.10.009","journal-title":"Phytomedicine"},{"issue":"1","key":"4566_CR167","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2478\/enr-2023-0019","volume":"57","author":"J Osacka","year":"2023","unstructured":"Osacka J, Kiss A, Bacova Z, Tillinger A (2023) Effects of antipsychotics, haloperidol and olanzapine, on the expression of apoptosis-related genes in mouse mHippoE-2 cells and rat hippocampus. Endocr Regul 57(1):152\u2013161","journal-title":"Endocr Regul"},{"issue":"2","key":"4566_CR168","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.expneurol.2006.08.009","volume":"203","author":"M Saldana","year":"2007","unstructured":"Saldana M, Bonastre M, Aguilar E, Marin C (2007) Differential nigral expression of Bcl-2 protein family in chronically haloperidol and clozapine-treated rats: role in neurotoxicity and stereotyped behavior. Exp Neurol 203(2):302\u2013308. https:\/\/doi.org\/10.1016\/j.expneurol.2006.08.009","journal-title":"Exp Neurol"},{"issue":"6","key":"4566_CR169","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jnr.10832","volume":"74","author":"Z Wei","year":"2003","unstructured":"Wei Z, Mousseau DD, Richardson JS, Dyck LE, Li XM (2003) Atypical antipsychotics attenuate neurotoxicity of \u03b2-amyloid (25\u201335) by modulating Bax and Bcl-Xl\/s expression and localization. J Neurosci Res 74(6):942\u2013947","journal-title":"J Neurosci Res"},{"issue":"3","key":"4566_CR170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0893-133X(01)00364-5","volume":"26","author":"A Post","year":"2002","unstructured":"Post A, Rucker M, Ohl F, Uhr M, Holsboer F, Almeida OF, Michaelidis TM (2002) Mechanisms underlying the protective potential of \u03b1-tocopherol (vitamin E) against haloperidol-associated neurotoxicity. Neuropsychopharmacology 26(3):397\u2013407","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"4566_CR171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37275\/scipsy.v1i2.6","volume":"1","author":"EG Panserga","year":"2020","unstructured":"Panserga EG, Kristanto CS, Pratiti B, Wulandari P (2020) Haloperidol and risperidone induce apoptosis neuronal cell: in vivo study. Scientia Psychiatrica 1(1):1\u20136","journal-title":"Scientia Psychiatrica"},{"issue":"1","key":"4566_CR172","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","volume":"36","author":"P Gass\u00f3","year":"2012","unstructured":"Gass\u00f3 P, Mas S, Molina O, Bernardo M, Lafuente A, Parellada E (2012) Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry 36(1):71\u201377","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"4566_CR173","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.npp.1301074","volume":"32","author":"LF Jarskog","year":"2007","unstructured":"Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, Lieberman JA (2007) Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology 32(1):95\u2013102","journal-title":"Neuropsychopharmacology"},{"key":"4566_CR174","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00702-004-0109-z","volume":"111","author":"W Ukai","year":"2004","unstructured":"Ukai W, Ozawa H, Tateno M, Hashimoto E, Saito T (2004) Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol. J Neural Transm 111:667\u2013681","journal-title":"J Neural Transm"},{"issue":"5","key":"4566_CR175","first-page":"323","volume":"32","author":"Y Dai","year":"2007","unstructured":"Dai Y, Wei Z, Sephton CF, Zhang D, Anderson DH, Mousseau DD (2007) Haloperidol induces the nuclear translocation of phosphatidylinositol 3\u2032-kinase to disrupt Akt phosphorylation in PC12 cells. J Psychiatry Neurosci 32(5):323\u2013330","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"4566_CR176","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cellsig.2008.10.005","volume":"21","author":"Z Wei","year":"2009","unstructured":"Wei Z, Qi J, Dai Y, Bowen WD, Mousseau DD (2009) Haloperidol disrupts Akt signalling to reveal a phosphorylation-dependent regulation of pro-apoptotic Bcl-XS function. Cell Signal 21(1):161\u2013168","journal-title":"Cell Signal"},{"key":"4566_CR177","doi-asserted-by":"crossref","first-page":"113297","DOI":"10.1016\/j.biopha.2022.113297","volume":"153","author":"S Bastani","year":"2022","unstructured":"Bastani S, Vahedian V, Rashidi M, Mir A, Mirzaei S, Alipourfard I, Pouremamali F, Nejabati H, et al (2022) An evaluation on potential anti-oxidant and anti-inflammatory effects of crocin. Biomed Pharmacother 153:113297","journal-title":"Biomed Pharmacother"},{"key":"4566_CR178","first-page":"85","volume":"2","author":"ET Olayinka","year":"2010","unstructured":"Olayinka ET, Olukowade I (2010) Effect of amoxycillin\/clavulanic acid (Augmentin 625\u00ae) on antioxidant indices and markers of renal and hepatic damage in rats. Toxicol Environ Health Sci 2:85\u201392","journal-title":"Toxicol Environ Health Sci"},{"issue":"6","key":"4566_CR179","doi-asserted-by":"publisher","first-page":"730","DOI":"10.22038\/ijbms.2020.39129.9287","volume":"23","author":"E Mohebbi","year":"2020","unstructured":"Mohebbi E, Molavi M, Mohammadzadeh M, Hosseinzadeh H, Amin B (2020) Clavulanic acid improves ethanol withdrawal symptoms in rats. Iran J Basic Med Sci 23(6):730\u2013736. https:\/\/doi.org\/10.22038\/ijbms.2020.39129.9287","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"4566_CR180","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10571-011-9752-8","volume":"32","author":"S Mehri","year":"2012","unstructured":"Mehri S, Abnous K, Mousavi SH, Shariaty VM, Hosseinzadeh H (2012) Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol 32(2):227\u2013235. https:\/\/doi.org\/10.1007\/s10571-011-9752-8","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"4566_CR181","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1665-2681(19)31792-2","volume":"8","author":"GA El-Sherbiny","year":"2009","unstructured":"El-Sherbiny GA, Taye A, Abdel-Raheem IT (2009) Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats. Ann Hepatol 8(2):134\u2013140","journal-title":"Ann Hepatol"},{"issue":"1","key":"4566_CR182","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1196\/annals.1329.054","volume":"1030","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB, Shishodia S (2004) Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030(1):434\u2013441. https:\/\/doi.org\/10.1196\/annals.1329.054","journal-title":"Ann N Y Acad Sci"},{"issue":"5A","key":"4566_CR183","first-page":"2783","volume":"24","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24(5A):2783\u20132840","journal-title":"Anticancer Res"},{"key":"4566_CR184","doi-asserted-by":"publisher","unstructured":"Fatemi R, Farbood Y, Fathimoghadam H, Ghadiri A (2022) Crocin attenuates pro-inflammatory cytokines and lipid proxidasion in rat brain following local injection with ethidium bromide. https:\/\/doi.org\/10.21203\/rs.3.rs-1936829\/v1","DOI":"10.21203\/rs.3.rs-1936829\/v1"},{"issue":"2","key":"4566_CR185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ddr.21381","volume":"78","author":"A Ochoa-Aguilar","year":"2017","unstructured":"Ochoa-Aguilar A, Sotomayor-Sobrino M, Jaimez R, Rodr\u00edguez R, Plancarte-S\u00e1nchez R, Ventura-Martinez R (2017) Antiallodynic activity of ceftriaxone and clavulanic acid in acute administration is associated with serum TNF-\u03b1 modulation and activation of dopaminergic and opioidergic systems. Drug Dev Res 78(2):105\u2013115","journal-title":"Drug Dev Res"},{"issue":"6","key":"4566_CR186","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S109285291700061X","volume":"22","author":"SM Stahl","year":"2017","unstructured":"Stahl SM (2017) Neuronal traffic signals in tardive dyskinesia: not enough \u201cstop\u201d in the motor striatum. CNS Spectr 22(6):427\u2013434","journal-title":"CNS Spectr"},{"issue":"9","key":"4566_CR187","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","volume":"34","author":"RA Vaughan","year":"2013","unstructured":"Vaughan RA, Foster JD (2013) Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci 34(9):489\u2013496","journal-title":"Trends Pharmacol Sci"},{"issue":"14","key":"4566_CR188","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1523\/JNEUROSCI.22-14-06272.2002","volume":"22","author":"Q Wu","year":"2002","unstructured":"Wu Q, Reith ME, Walker QD, Kuhn CM, Carroll FI, Garris PA (2002) Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci 22(14):6272\u20136281. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-14-06272.2002","journal-title":"J Neurosci"},{"issue":"9","key":"4566_CR189","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/s41380-018-0114-5","volume":"25","author":"D Amato","year":"2020","unstructured":"Amato D, Canneva F, Cumming P, Maschauer S, Groos D, Dahlmanns JK, Gromer TW, Chiofalo L, et al (2020) A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Mol Psychiatry 25(9):2101\u20132118. https:\/\/doi.org\/10.1038\/s41380-018-0114-5","journal-title":"Mol Psychiatry"},{"key":"4566_CR190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fpsyt.2019.00314","volume":"10","author":"D Amato","year":"2019","unstructured":"Amato D, Kruyer A, Samaha A-N, Heinz A (2019) Hypofunctional dopamine uptake and antipsychotic treatment-resistant schizophrenia. Front Psych 10:314","journal-title":"Front Psych"},{"issue":"2\u20133","key":"4566_CR191","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.schres.2004.03.015","volume":"71","author":"KK Yoder","year":"2004","unstructured":"Yoder KK, Hutchins GD, Morris ED, Brashear A, Wang C, Shekhar A (2004) Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia. Schizophr Res 71(2\u20133):371\u2013375","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"4566_CR192","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mam.2012.07.005","volume":"34","author":"HO Lawal","year":"2013","unstructured":"Lawal HO, Krantz DE (2013) SLC18: vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med 34(2\u20133):360\u2013372","journal-title":"Mol Aspects Med"},{"key":"4566_CR193","doi-asserted-by":"publisher","first-page":"172872","DOI":"10.1016\/j.pbb.2020.172872","volume":"190","author":"M Huang","year":"2020","unstructured":"Huang M, He W, Rajagopal L, Kudwa A, Grigoriadis DE, Meltzer HY (2020) Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: relevance to tardive dyskinesia and antipsychotic action. Pharmacol Biochem Behav 190:172872. https:\/\/doi.org\/10.1016\/j.pbb.2020.172872","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"4566_CR194","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0924-977x(02)00021-4","volume":"12","author":"M Rehavi","year":"2002","unstructured":"Rehavi M, Roz N, Weizman A (2002) Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2. Eur Neuropsychopharmacol 12(3):261\u2013268. https:\/\/doi.org\/10.1016\/s0924-977x(02)00021-4","journal-title":"Eur Neuropsychopharmacol"},{"key":"4566_CR195","first-page":"153","volume":"2","author":"G Selvakumar","year":"2012","unstructured":"Selvakumar G, Vijayraja D, Krishnamoorthy D, Manivasagam T (2012) Morin attenuates haloperidol induced tardive dyskinesia and oxidative stress in mice. J Nat Sci Res 2:153\u2013165","journal-title":"J Nat Sci Res"},{"issue":"1","key":"4566_CR196","first-page":"1","volume":"7","author":"T Farkhondeh","year":"2018","unstructured":"Farkhondeh T, Samarghandian S, Shaterzadeh Yazdi H, Samini F (2018) The protective effects of crocin in the management of neurodegenerative diseases: a review. Am J Neurodegener Dis 7(1):1\u201310","journal-title":"Am J Neurodegener Dis"},{"key":"4566_CR197","doi-asserted-by":"crossref","first-page":"107559","DOI":"10.1016\/j.neuropharm.2019.03.002","volume":"161","author":"E Pajarillo","year":"2019","unstructured":"Pajarillo E, Rizor A, Lee J, Aschner M, Lee E (2019) The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics. Neuropharmacology 161:107559","journal-title":"Neuropharmacology"},{"key":"4566_CR198","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnmol.2019.00164","volume":"12","author":"AR Peterson","year":"2019","unstructured":"Peterson AR, Binder DK (2019) Post-translational regulation of GLT-1 in neurological diseases and its potential as an effective therapeutic target. Front Mol Neurosci 12:164","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"4566_CR199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0173(94)90002-7","volume":"19","author":"JA Angulo","year":"1994","unstructured":"Angulo JA, McEwen BS (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Rev 19(1):1\u201328","journal-title":"Brain Res Rev"},{"issue":"1","key":"4566_CR200","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00002826-199302000-00012","volume":"16","author":"LM Gunne","year":"1993","unstructured":"Gunne LM, Andren PE (1993) An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia. Clin Neuropharmacol 16(1):90\u201395. https:\/\/doi.org\/10.1097\/00002826-199302000-00012","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"4566_CR201","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00001756-199801050-00026","volume":"9","author":"JS Schneider","year":"1998","unstructured":"Schneider JS, Wade T, Lidsky TI (1998) Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum. NeuroReport 9(1):133\u2013136. https:\/\/doi.org\/10.1097\/00001756-199801050-00026","journal-title":"NeuroReport"},{"issue":"2","key":"4566_CR202","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0014-2999(99)00589-0","volume":"382","author":"IE De Souza","year":"1999","unstructured":"De Souza IE, McBean GJ, Meredith GE (1999) Chronic haloperidol treatment impairs glutamate transport in the rat striatum. Eur J Pharmacol 382(2):139\u2013142. https:\/\/doi.org\/10.1016\/s0014-2999(99)00589-0","journal-title":"Eur J Pharmacol"},{"key":"4566_CR203","doi-asserted-by":"crossref","unstructured":"Amin B, Avaznia M, Noorani R, Mehri S, Hosseinzadeh HJB (2019) neuroscience c Upregulation of glutamate transporter 1 by clavulanic acid administration and attenuation of allodynia and hyperalgesia in neuropathic rats. 10 (4):345","DOI":"10.32598\/bcn.10.4.799.2"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04566-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:13:04Z","timestamp":1741083184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":203,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4566"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04566-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was granted by the Ethics Committee of Mashhad University of Medical Sciences (941406).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}